Literature DB >> 19030025

Regulating the stability of TGFbeta receptors and Smads.

Peter Lönn1, Anita Morén, Erna Raja, Markus Dahl, Aristidis Moustakas.   

Abstract

Transforming growth factor beta (TGFbeta) controls cellular behavior in embryonic and adult tissues. TGFbeta binding to serine/threonine kinase receptors on the plasma membrane activates Smad molecules and additional signaling proteins that together regulate gene expression. In this review, mechanisms and models that aim at explaining the coordination between several components of the signaling network downstream of TGFbeta are presented. We discuss how the activity and duration of TGFbeta receptor/Smad signaling can be regulated by post-translational modifications that affect the stability of key proteins in the pathway. We highlight links between these mechanisms and human diseases, such as tissue fibrosis and cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19030025     DOI: 10.1038/cr.2008.308

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  84 in total

1.  The role of SnoN in transforming growth factor beta1-induced expression of metalloprotease-disintegrin ADAM12.

Authors:  Emilia Solomon; Hui Li; Sara Duhachek Muggy; Emilia Syta; Anna Zolkiewska
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Differentiated intestinal epithelial cells express high levels of TGF-β receptors and exhibit increased sensitivity to growth inhibition.

Authors:  Navneeta Rathor; Shelley R Wang; Elizabeth T Chang; Jaladanki N Rao
Journal:  Int J Clin Exp Med       Date:  2011-11-10

3.  DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition.

Authors:  Nanyue Chen; Seetharaman Balasenthil; Jacquelyn Reuther; Aileen Frayna; Ying Wang; Dawn S Chandler; Lynne V Abruzzo; Asif Rashid; Jaime Rodriguez; Guillermina Lozano; Yu Cao; Erica Lokken; Jinyun Chen; Marsha L Frazier; Aysegul A Sahin; Ignacio I Wistuba; Subrata Sen; Steven T Lott; Ann McNeill Killary
Journal:  Cancer Discov       Date:  2013-07-09       Impact factor: 39.397

4.  Modulation of type II TGF-β receptor degradation by integrin-linked kinase.

Authors:  Linda Vi; Stellar Boo; Samar Sayedyahossein; Randeep K Singh; Sarah McLean; Gianni M Di Guglielmo; Lina Dagnino
Journal:  J Invest Dermatol       Date:  2014-09-30       Impact factor: 8.551

Review 5.  Specificity, versatility, and control of TGF-β family signaling.

Authors:  Rik Derynck; Erine H Budi
Journal:  Sci Signal       Date:  2019-02-26       Impact factor: 8.192

Review 6.  The microRNA networks of TGFβ signaling in cancer.

Authors:  V P Sivadas; S Kannan
Journal:  Tumour Biol       Date:  2013-12-10

7.  Betaglycan alters NFκB-TGFβ2 cross talk to reduce survival of human granulosa tumor cells.

Authors:  Maree Bilandzic; Simon Chu; Yao Wang; Han L Tan; Peter J Fuller; Jock K Findlay; Kaye L Stenvers
Journal:  Mol Endocrinol       Date:  2013-01-15

8.  TGFβRIIb mutations trigger aortic aneurysm pathogenesis by altering transforming growth factor β2 signal transduction.

Authors:  Katharine J Bee; David C Wilkes; Richard B Devereux; Craig T Basson; Cathy J Hatcher
Journal:  Circ Cardiovasc Genet       Date:  2012-10-24

9.  Expression of USP15, TβR-I and Smad7 in psoriasis.

Authors:  Ai-Ping Feng; Yi-Min He; Xin-Xin Liu; Jia-Wen Li; Ya-Ting Tu; Feng Hu; Shan-Juan Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

10.  Smad2 and Smad6 as predictors of overall survival in oral squamous cell carcinoma patients.

Authors:  Flavia R R Mangone; Fernando Walder; Simone Maistro; Fátima S Pasini; Carlos N Lehn; Marcos B Carvalho; M Mitzi Brentani; Igor Snitcovsky; Miriam H H Federico
Journal:  Mol Cancer       Date:  2010-05-12       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.